Accessing pharmacotherapy (opioid replacement therapy) during COVID-19

Alcohol and Drug Foundation (Australia), April 27th 2020

There are now new challenges for people who access opioid replacement therapy (ORT) due to the COVID-19 (coronavirus) pandemic. Many may be experiencing anxiety and fear due to COVID-19 and trying to reduce and mitigate these feelings is vital.

In most cases, people who are on ORT are required to visit their health clinic or pharmacy on a daily basis. This can be more difficult for people right now, due to restrictions on movement and the social distancing regulations imposed to curtail COVID-19.

 

Keeping up with hepatitis, liver, and COVID-19 resources

Hepatitis SA, May 2020

Hepatitis SA currently have a collection of hepatitis/liver related COVID-19 resources available online through their library catalogue.

Hepatitis SA maintains a specialist library of physical and online resources; including books, reports, audio-visual resources, journals and newsletters, with the services of a professional librarian.

 

 

COVID-19 and viral hepatitis FAQs  in English, Korean, Chinese

Hepatitis NSW, May 2020

Since the COVID-19 virus is so new and can be life threatening, there are many unknown factors at play. This is even more so for people with pre-existing health conditions to consider. To help address those concerns and to answer the frequently asked questions, Hepatitis NSW has now compiled a number of online resources. 

All pages are based on the most up to date information and will be updated frequently.